These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16728216)

  • 41. [Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis].
    Greig D; Corbalán R; Castro P; Campos P; Lamich R; Yovaniniz P
    Rev Med Chil; 2008 Sep; 136(9):1098-106. PubMed ID: 19030652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.
    Gibson CM; Dumaine RL; Gelfand EV; Murphy SA; Morrow DA; Wiviott SD; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    Eur Heart J; 2004 Nov; 25(22):1998-2005. PubMed ID: 15541835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome.
    Kolman L; Hu YC; Montgomery DG; Gordon K; Eagle KA; Jackson EA
    Am J Cardiol; 2009 Aug; 104(4):470-4. PubMed ID: 19660596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.
    Omland T; Ueland T; Jansson AM; Persson A; Karlsson T; Smith C; Herlitz J; Aukrust P; Hartford M; Caidahl K
    J Am Coll Cardiol; 2008 Feb; 51(6):627-33. PubMed ID: 18261681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study.
    Janszky I; Hallqvist J; Ljung R; Ahlbom A; Hammar N
    J Intern Med; 2009 Apr; 265(4):465-75. PubMed ID: 19019187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.
    Núñez J; Núñez E; Bodí V; Sanchis J; Miñana G; Mainar L; Santas E; Merlos P; Rumiz E; Darmofal H; Heatta AM; Llàcer A
    Am J Cardiol; 2008 Mar; 101(6):747-52. PubMed ID: 18328833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
    Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
    Khan SQ; Quinn P; Davies JE; Ng LL
    Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of diagnosis and sex on long-term prognosis in acute coronary syndromes.
    Perers E; Caidahl K; Herlitz J; Karlsson T; Hartford M
    Am Heart J; 2007 Sep; 154(3):482-8. PubMed ID: 17719294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively.
    Dziewierz A; Giszterowicz D; Siudak Z; Rakowski T; Mielecki W; Suska M; Dubiel JS; Dudek D
    Am J Cardiol; 2009 Apr; 103(7):954-8. PubMed ID: 19327422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.
    Ho PM; Fihn SD; Wang L; Bryson CL; Lowy E; Maynard C; Magid DJ; Peterson ED; Jesse RL; Rumsfeld JS
    Am Heart J; 2007 Nov; 154(5):846-51. PubMed ID: 17967588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial serum glucose level as a prognostic factor in the first acute myocardial infarction.
    Hsu CW; Chen HH; Sheu WH; Chu SJ; Shen YS; Wu CP; Chien KL
    Ann Emerg Med; 2007 May; 49(5):618-26. PubMed ID: 17178170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure.
    Barsheshet A; Garty M; Grossman E; Sandach A; Lewis BS; Gottlieb S; Shotan A; Behar S; Caspi A; Schwartz R; Tenenbaum A; Leor J
    Arch Intern Med; 2006 Aug 14-28; 166(15):1613-9. PubMed ID: 16908794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.
    Kempf T; Björklund E; Olofsson S; Lindahl B; Allhoff T; Peter T; Tongers J; Wollert KC; Wallentin L
    Eur Heart J; 2007 Dec; 28(23):2858-65. PubMed ID: 17977844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of myocardial reperfusion in patients with fasting blood glucose < or =100, 101 to 125, and >125 mg/dl and ST-elevation myocardial infarction with percutaneous coronary intervention.
    Fefer P; Hod H; Ilany J; Shechter M; Segev A; Novikov I; Guetta V; Matetzky S
    Am J Cardiol; 2008 Dec; 102(11):1457-62. PubMed ID: 19026295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.